Request Demo
Last update 11 Jul 2026
SAL0150
Last update 11 Jul 2026
Overview
Basic Info
Drug Type Biological products |
Synonyms- |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with SAL0150CTR20261095
SAL0150片在健康试验参与者和肥胖试验参与者中单次和多次给药的安全性、耐受性、药代动力学和药效学研究
[Translation] Safety, tolerability, pharmacokinetics, and pharmacodynamics studies of SAL0150 tablets with single and multiple doses in healthy and obese trial participants.
CTR20261686
评价不同给药方式对中国健康成年试验参与者口服SAL0150片药代动力学影响的研究
[Translation] A study evaluating the effects of different administration routes on the pharmacokinetics of SAL0150 tablets in healthy adult Chinese participants.
CTR20261656
评价SAL0150片与盐酸二甲双胍片在健康试验参与者中的单中心、开放、单用及联合用药药代动力学的研究
[Translation] A single-center, open-label, monotherapy and combination pharmacokinetic study evaluating SAL0150 tablets and metformin hydrochloride tablets in healthy trial participants.
100 Clinical Results associated with SAL0150
Login to view more data
100 Translational Medicine associated with SAL0150
Login to view more data
100 Patents (Medical) associated with SAL0150
Login to view more data
100 Deals associated with SAL0150
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 1 | China | 31 Mar 2026 | |
| Intermittent Claudication | Phase 1 | China | 31 Mar 2026 | |
| Peripheral Arterial Disease | Phase 1 | China | 31 Mar 2026 | |
| Dyslipidemias | IND Approval | China | 20 Mar 2026 | |
| Fatty Liver | IND Approval | China | 20 Mar 2026 | |
| Hypertension | IND Approval | China | 20 Mar 2026 | |
| Polycystic Ovary Syndrome | IND Approval | China | 20 Mar 2026 | |
| Sleep Apnea, Obstructive | IND Approval | China | 20 Mar 2026 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free